Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptidoglycan adjuvants: minimal structure required for activity.

A Adam, F Ellouz, R Ciorbaru

    Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie
    |July 1, 1975
    PubMed
    Summary

    The smallest active immune-boosting compound identified is N-acetyl-muramyl-L-alanyl-D-isoglutamine. This smallest adjuvant active fraction is derived from mycobacterial cell walls, enhancing both humoral and cellular immunity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Esophageal cancer: self-expanding metallic stents.

    Abdominal imaging·2005
    Same author

    Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks.

    Journal of chemical neuroanatomy·2004
    Same author

    The use of SMARTeR stents in patients with biliary obstruction.

    Clinical radiology·2004
    Same author

    Trans-oral embolization of a post-operative duodenocutaneous fistula.

    Clinical radiology·2003
    Same author

    Registration of freehand 3D ultrasound and magnetic resonance liver images.

    Medical image analysis·2003
    Same author

    Bronchogastric fistula successfully treated with the insertion of a covered bronchial stent.

    European radiology·2003

    Area of Science:

    • Immunology
    • Microbiology
    • Organic Chemistry

    Background:

    • Soluble peptidoglycan fragments from mycobacterial cell walls are known adjuvants.
    • These fragments enhance both humoral and cellular immunity.
    • The chemical structure of these adjuvant-active fractions is under investigation.

    Purpose of the Study:

    • To investigate the chemical structure of the adjuvant-active fraction of mycobacterial cell walls.
    • To identify the smallest molecular subunit responsible for adjuvant activity.

    Main Methods:

    • Lysozyme digestion of mycobacterial cell walls to obtain soluble peptidoglycan fragments.
    • Testing of monomeric subunits of peptidoglycans from various bacterial strains for adjuvant activity.
    • Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine for activity assessment.

    Related Experiment Videos

    Main Results:

    • Soluble peptidoglycan fragments from Mycobacteria exhibit adjuvant properties.
    • The monomer subunit (disaccharide-tetrapeptide) of mycobacterial peptidoglycan is also adjuvant-active.
    • Adjuvant activity was confirmed for monomeric subunits of peptidoglycans containing meso-diaminopimelic acid and L-lysine.
    • N-acetyl-muramyl-L-alanyl-D-isoglutamine was identified as the smallest active compound studied.

    Conclusions:

    • The adjuvant activity of mycobacterial cell walls is attributed to peptidoglycan subunits.
    • The minimal active structure is N-acetyl-muramyl-L-alanyl-D-isoglutamine.
    • This finding has implications for the development of new immunomodulatory agents.